{
    "2020-07-09": [
        [
            {
                "time": "",
                "orginal_text": "【民生医药|公司深度】博腾股份：CRO导流，能力提升，进入成长快车道CDMO公司",
                "features": {
                    "keywords": [
                        "博腾股份",
                        "CRO",
                        "CDMO",
                        "能力提升",
                        "成长快车道"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CDMO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医药外包行业系列深度报告之三：“API+”：全球产业大转移 褪去周期迎成长",
                "features": {
                    "keywords": [
                        "医药外包",
                        "API+",
                        "全球产业转移",
                        "褪去周期",
                        "成长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "外包行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "高瓴火速再出手：这两家公司市值大涨170亿",
                "features": {
                    "keywords": [
                        "高瓴",
                        "市值大涨",
                        "投资"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "上半年股基冠军经理皮劲松：医药行业长期发展空间大",
                "features": {
                    "keywords": [
                        "皮劲松",
                        "医药行业",
                        "长期发展",
                        "空间大"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}